A Practical DNA Molecular Computing Platform for Identifying Expression Patterns of Multiple miRNAs Related to Diseases

MicroRNAs (miRNAs) have emerged as potential biomarkers for human diseases. Classification models established on the expression levels of multiple miRNAs can be used to realize a reliable diagnosis of diseases. The detection of expression patterns of multiple miRNAs using traditional methods is generally cost-prohibitive, labor-intensive, and limited by the requirements of sophisticated facilities. DNA molecular computing technology attempts to implement a multiple-miRNA-based disease classification model through reactions among DNA probes and miRNAs without the need to quantify each individual miRNA, and hence has the potential to realize fast and cheap clinical diagnosis of early-stage diseases. However, existing DNA molecular computing frameworks for disease diagnosis struggle in faithfully implementing even linear classification models with nonzero classification thresholds, which hinders their practical clinical applications. Herein, for the first time, a novel DNA molecular computing platform enabling full and accurate implementation of multiple-miRNA-based disease classification models is proposed. It consists of "multiplication," "addition," "calibration," and "diagnosis" modules. The first two modules are implemented experimentally through "one-pot" reactions among DNA probes and miRNAs, while the last two modules are carried out in silico. Experimental results have demonstrated that such a hybrid implementation strategy breaks through the bottleneck of conventional DNA molecular computing frameworks for disease diagnosis, and faithfully implements a disease classifier for discriminating diseased samples from normal ones. The new platform has the advantages of reduced design complexity, easy experimental implementation, and robustness to variations in signal amplification factors across samples, and opens up an avenue for point-of-care clinical diagnosis of early-stage diseases.

Authors

Institutions

Publication Details

Journal
Analytical Chemistry
Published
2026-05-12
DOI
https://doi.org/10.1021/acs.analchem.6c01580
Primary Topic
Gene expression and cancer classification
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Practical DNA Molecular Computing Platform for Identifying Expression Patterns of Multiple miRNAs Related to Diseases

Zeng‐Ping Chen, Ziru Tang, Jinghao Fu, Jun Zeng et al.
Analytical Chemistry
Gene expression and cancer classification
article

A Practical DNA Molecular Computing Platform for Identifying Expression Patterns of Multiple miRNAs Related to Diseases

Zeng‐Ping Chen, Ziru Tang, Jinghao Fu, Jun Zeng, Yuehua Chen, De-Huan Yang, Ru-Qin Yu
article en

Abstract

MicroRNAs (miRNAs) have emerged as potential biomarkers for human diseases. Classification models established on the expression levels of multiple miRNAs can be used to realize a reliable diagnosis of diseases. The detection of expression patterns of multiple miRNAs using traditional methods is generally cost-prohibitive, labor-intensive, and limited by the requirements of sophisticated facilities. DNA molecular computing technology attempts to implement a multiple-miRNA-based disease classification model through reactions among DNA probes and miRNAs without the need to quantify each individual miRNA, and hence has the potential to realize fast and cheap clinical diagnosis of early-stage diseases. However, existing DNA molecular computing frameworks for disease diagnosis struggle in faithfully implementing even linear classification models with nonzero classification thresholds, which hinders their practical clinical applications. Herein, for the first time, a novel DNA molecular computing platform enabling full and accurate implementation of multiple-miRNA-based disease classification models is proposed. It consists of "multiplication," "addition," "calibration," and "diagnosis" modules. The first two modules are implemented experimentally through "one-pot" reactions among DNA probes and miRNAs, while the last two modules are carried out in silico. Experimental results have demonstrated that such a hybrid implementation strategy breaks through the bottleneck of conventional DNA molecular computing frameworks for disease diagnosis, and faithfully implements a disease classifier for discriminating diseased samples from normal ones. The new platform has the advantages of reduced design complexity, easy experimental implementation, and robustness to variations in signal amplification factors across samples, and opens up an avenue for point-of-care clinical diagnosis of early-stage diseases.

Analytical Chemistry
Hunan University (CN), Advanced Materials and Devices (United States) (US), Hunan University of Technology (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 8%
Gene expression and cancer classification
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.